NCT00851734 · Interventional trial
A Dose-Escalation Study to Assess the Safety and Tolerability of LX214 Ophthalmic Solution in Healthy Volunteers, Followed by an Open-Label Evaluation of LX214 in Patients With Keratoconjunctivitis Sicca (KCS)
Overall registry status Completed
Phase 1
Conditions Keratoconjunctivitis Sicca
Delaware Valley sites
- Product Investigations · Conshohocken, PA · Montgomery County
First posted
Registry updated
Added to the directory